Literature DB >> 8415237

Therapeutic drug monitoring. Principles and practice.

S H Preskorn1, M J Burke, G A Fast.   

Abstract

TDM represents an important tool in the optimal use of selected psychiatric medications. Its role in therapy varies depending on the drug being prescribed. For some medications, such as lithium and tricyclic antidepressants, it should be a standard aspect of care. For other drugs, such as benzodiazepines, it is not helpful. Unfortunately, the use of TDM often follows an "all or none" pattern. Some clinicians rarely use it even for drugs like TCAs where it is critical to optimal care. Others use it excessively; repeating levels when it is not necessary or for drugs for which it is not necessary. It is hoped that this article has provided a basis for the thoughtful application of TDM in psychiatry as well as a review of the available data.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8415237

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  9 in total

Review 1.  Therapeutic drug monitoring of antidepressants: cost implications and relevance to clinical practice.

Authors:  M J Burke; S H Preskorn
Journal:  Clin Pharmacokinet       Date:  1999-08       Impact factor: 6.447

2.  Comprehensive survey of the relationship between serum concentration and therapeutic effect of amitriptyline in depression.

Authors:  Sven Ulrich; Jürgen Läuter
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 3.  Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.

Authors:  Eveline Jaquenoud Sirot; Jan Willem van der Velden; Katharina Rentsch; Chin B Eap; Pierre Baumann
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

4.  Imipramine dose in relation to therapeutic plasma level: are clinical trials using imipramine as a positive control flawed?

Authors:  Tom K Birkenhäger; Walter W van den Broek; Peter Moleman; Arnold G Vulto; Jan A Bruijn
Journal:  Psychopharmacology (Berl)       Date:  2005-10-12       Impact factor: 4.530

Review 5.  The relationship between serum concentration and therapeutic effect of haloperidol in patients with acute schizophrenia.

Authors:  S Ulrich; C Wurthmann; M Brosz; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1998-03       Impact factor: 6.447

Review 6.  Therapeutic drug monitoring in neuropsychopharmacology: does it hold its promises?

Authors:  Christoph Hiemke
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-03       Impact factor: 5.270

Review 7.  Therapeutic drug monitoring for the treatment of psychiatric disorders. Clinical use and cost effectiveness.

Authors:  R Eilers
Journal:  Clin Pharmacokinet       Date:  1995-12       Impact factor: 6.447

8.  The role of the affective temperament in the treatment adherence in psychiatry.

Authors:  Lilia Bahrini; Rahma Damak; Mejda Cheour
Journal:  Pan Afr Med J       Date:  2016-09-02

9.  Is Therapeutic Drug Monitoring Relevant for Antidepressant Drug Therapy? Implications From a Systematic Review and Meta-Analysis With Focus on Moderating Factors.

Authors:  Cleo S M Funk; Xenia M Hart; Gerhard Gründer; Christoph Hiemke; Björn Elsner; Reinhold Kreutz; Thomas G Riemer
Journal:  Front Psychiatry       Date:  2022-02-21       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.